Neuropeptide Y Receptor Type 2 Pipeline Review, H2 2019
Summary
Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R Neuropeptide Y receptor type 2 Y2R is a protein encoded by the NPY2R gene. It is expressed abundantly in the central nervous system. It is also seen in the spleen, liver and intestine. It regulates the release of neurotransmitters by functioning as an autoreceptor and heteroreceptor.
Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R pipeline Target constitutes close to 6 molecules. The molecules developed by companies in Phase I, Preclinical and Discovery stages are 2, 3 and 1 respectively. Report covers products from therapy areas Metabolic Disorders and Central Nervous System which include indications Obesity and Epilepsy.
The latest report Neuropeptide Y Receptor Type 2 Pipeline Review, H2 2019, outlays comprehensive information on the Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type. It also reviews key players involved in Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R targeted therapeutics development with respective active and dormant or discontinued projects.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources.
Scope
The report provides a snapshot of the global therapeutic landscape for Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R
The report reviews Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources
The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities
The report reviews key players involved in Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R targeted therapeutics and enlists all their major and minor projects
The report assesses Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type
The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news and deals related to Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R targeted therapeutics
Reasons to buy
Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Identify and understand the targeted therapy areas and indications for Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R
Identify the use of drugs for target identification and drug repurposing
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Neuropeptide Y Receptor Type 2 NPY Y2 Receptor or NPY2R development landscape
Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope